Verified· 2 sources

SwissBiotech SA

Summary

About the company

SwissBiotech SA develops ChondroNest™, a biopolymer-based product for in‑situ reconstruction and regeneration of cartilage extracellular matrix using minimally invasive techniques. The company focuses on tissue-engineering research, prototype characterisation and preclinical testing, and plans to license additional applications such as bone reconstruction and reconstructive/aesthetic surgery to third parties.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered3

Osteoarthritis treatment (ChondroNest™)

Osteoarthritis treatment using tissue engineering, reconstruction of the cartilage extracellular matrix based on natural biopolymers, a minimally invasive approach for small and complex joints.

Cartilage tissue engineering

Development of a technology for reconstructing and regenerating the cartilage extracellular matrix in situ, for the treatment and revitalisation of the biomimetic joint.

Licensing of tissue engineering technologies

Licensing of other application fields of the patented technology, in particular bone reconstruction, aesthetic and reconstructive surgery, to third parties.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

SwissBiotech SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

SwissBiotech SA

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

SwissBiotech SA in comparison

Industry comparisons are coming soon

Similar companies